Discussion  by unknown
Shudo et al Evolving Technology/Basic Scienceto recruit stem cells to the site of damage, where they pro-
mote heart repair.6 Nevertheless, it remains to be deter-
mined what cytokines play a major role in generating
therapeutic effects among the many complex molecular
and cellular mechanisms involved.
We could find no ventricular premature beat by Holter
electrocardiographic analysis after the treatment (data not
shown). We5 previously reported that rat and porcine MI
models show less arrhythmia after being treated with
SMB-sheet implantation than with needle injection. We
speculate that the needle damages the myocardium, which
may induce arrhythmia. In contrast, the SMB sheet implan-
tation technique does not normally injure the myocardium.
Moreover, we did not observe any cases of lethal ventricular





A new cell-delivery method using SMB sheets combined
with omentum allowed us to implant large numbers of
SMBs in a porcine MI model. The implanted sheets became
well-vascularized cardiac tissue, with less scarring and im-
proved cardiac function over that of the animals receiving
SMB sheets alone. This method may be applicable for re-
pairing the severely failing heart.
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I thank the authors for the courtesy of providing me with a copy
of their manuscript well in advance of the meeting. I congratulate
them as well for a very elegantly performed and executed study,
and I will confirm with the audience that the results shown here
are just a small tip of the iceberg of the complete results presented
in the manuscript. Most important, the manuscript contains a lot of
functional data that, unfortunately, owing to time constraints,
Dr Shudo was unable to present.
Having said that, I have a few questions with regard to this
study. In the manuscript, it was not quite clear to me whether the
number of cell sheets delivered were different between the omen-
tum group (O group) and the cell-sheets-only group (S group). You
mentioned that to achieve the omentumwrapping you had a limita-
tion of 5 sheets in the omentum-plus-cell group (SO group). Was
that different from the total number of cell sheets implanted in
the cell-sheets-only group (S group)?
Dr Shudo. Thank you for your useful comments, Dr Rao.
In this study we used 30 cell sheets total. On the basis of our re-
sults in the previous studies, the increase in the number of im-
planted cell sheets was related to the favorable results, such as
enhancing the paracrine effect and improving cardiac function.
However, these previous studies also suggested that more than 5
layers of SMB sheets had disorganized vasculature in the im-
planted site, maybe owing to the primary ischemia. Therefore, in
this study, at most 5 layers were attached in one place and covered
and wrapped with the omentum to support the angiogenesis.
Dr Rao. I will point to some of the LV function data that were
presented in your manuscript. You measured LV function both at 4
weeks and 8 weeks after LAD ligation. What was striking to me
was that in most models of LAD ligation there is continued dete-
rioration in LV function in the control groups. In contrast, in your
study, the 3 relative control groups had stabilization of their LVdiovascular Surgery c Volume 142, Number 5 1195




Sfunction from 4 to 8 weeks with a continued improvement in LV
function in the omentum-plus-cell-transplant group (SO group).
Can you explain why the LV function appeared to stabilize in
your model.
Dr Shudo. In this study,MIwas induced by first ligating the dis-
tal portion of the LAD for ischemic preconditioning, followed by
placement of the ameroid constrictor around the main trunk of the
LAD, just distal to the left circumflex artery branching. It has been
reported that the ameroid ring was estimated to occlude inside
completely about 2 weeks after being placed in vivo. As you men-
tioned (and as shown in one slide), LVEF seems to be unchanged 1,
2, and 3 months after placement of the ameroid ring, whereas
LVEDVand LVESV indices significantly increased gradually after
induction of MI. Therefore, I would like to mention that LV re-
modeling was successfully obtained in this model in this study.
Dr Rao. I have 1 final question. You showed that the cell reten-
tion was approximately double that with the addition of the omen-
tum wrapping, 60% cell retention versus 30% with the cell sheet
alone. Yet for almost all of your end points there was absolutely
no benefit to cell sheet implantation alone, which is obviously in
contrast to many of the studies done previously with SMBs show-
ing a benefit in function, angiogenesis, et cetera. Can you explain
why your cell sheet transplant alone had absolutely no benefit in
this model.1196 The Journal of Thoracic and Cardiovascular SurDr Shudo. That seems to be a bit confusing. We have obtained
good results even in the cell-sheet-only group (S group), too. How-
ever, we would like to focus on the preferable results of the new
cell-implantation method.
Thank you again for your comments and good questions.
Dr Paul Kurlansky (Miami, Fla). I have no disclosures.
This was very interesting work. I have just 2 questions. First,
what exact cells or mixture of cells are you putting into the cell
sheets? Second, have you looked histologically at the hearts to
see if you actually have myocardial regeneration or if you just
have hypertrophy and preservation of the residual border zone
myocardium?
Dr Shudo. Thank you so much. Regarding the first question, al-
though this is unpublished information, we performed the experi-
mental study about SMBs mixed with adipose tissue, derived
mesenchymal stem cells. This model shows priority to the SMB
cell-sheet-only group (S group).
Regarding the analysis of border zone, our study using tissue
Doppler echocardiography and speckle tracking echocardiogra-
phy data showed that regional functional recovery was signifi-
cantly greater in the infarct border region. This result may
support the idea that cell-sheet-with-omentum therapy pre-
vented progression of MI by supporting the hibernating
myocardium.gery c November 2011
